These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37372545)

  • 21. Biotransformation of soy isoflavone-glycosides in laying hens: intestinal absorption and preferential accumulation into egg yolk of equol, a more estrogenic metabolite of daidzein.
    Saitoh S; Sato T; Harada H; Matsuda T
    Biochim Biophys Acta; 2004 Sep; 1674(2):122-30. PubMed ID: 15374616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equol-producing status affects exercise training-induced improvement in arterial compliance in postmenopausal women.
    Hayashi K; Yamaguchi H; Amaoka H; Takahara T; Kunisa S; Tamai N; Maejima N; Watanabe N; Kobayashi Y; Tanaka H
    J Appl Physiol (1985); 2021 Mar; 130(3):827-835. PubMed ID: 33356982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Use of a Real-Time Quantitative PCR Method for Detecting and Quantifying Equol-Producing Bacteria in Human Faecal Samples and Slurry Cultures.
    Vázquez L; Guadamuro L; Giganto F; Mayo B; Flórez AB
    Front Microbiol; 2017; 8():1155. PubMed ID: 28713336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions.
    Polimeno L; Barone M; Mosca A; Viggiani MT; Joukar F; Mansour-Ghanaei F; Mavaddati S; Daniele A; Debellis L; Bilancia M; Santacroce L; Di Leo A
    Microorganisms; 2020 Mar; 8(4):. PubMed ID: 32218321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-(-)equol production is developmentally regulated and related to early diet composition.
    Brown NM; Galandi SL; Summer SS; Zhao X; Heubi JE; King EC; Setchell KD
    Nutr Res; 2014 May; 34(5):401-9. PubMed ID: 24916553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of recombinant lactic acid bacteria and bifidobacteria able to enrich soy beverage in dihydrodaidzein and dihydrogenistein.
    Peirotén Á; Gaya P; Mª Landete J
    Food Res Int; 2020 Aug; 134():109257. PubMed ID: 32517924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.
    Duncan AM; Merz-Demlow BE; Xu X; Phipps WR; Kurzer MS
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):581-6. PubMed ID: 10868692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of Soy Isoflavones by Intestinal Bacteria: Genome Analysis of an
    Vázquez L; Flórez AB; Redruello B; Mayo B
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women.
    Pusparini ; Yenny ; Hidayat A
    Endocr Metab Immune Disord Drug Targets; 2015; 15(1):71-9. PubMed ID: 25441486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized rats.
    Legette LL; Prasain J; King J; Arabshahi A; Barnes S; Weaver CM
    J Agric Food Chem; 2014 Feb; 62(6):1294-300. PubMed ID: 24446705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
    Atkinson C; Frankenfeld CL; Lampe JW
    Exp Biol Med (Maywood); 2005 Mar; 230(3):155-70. PubMed ID: 15734719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
    Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
    Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation.
    Törmälä R; Appt S; Clarkson TB; Groop PH; Rönnback M; Ylikorkala O; Mikkola TS
    Atherosclerosis; 2008 May; 198(1):174-8. PubMed ID: 17961576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of S-equol and natural S-equol supplement (SE5-OH) on the growth of MCF-7 in vitro and as tumors implanted into ovariectomized athymic mice.
    Onoda A; Ueno T; Uchiyama S; Hayashi S; Kato K; Wake N
    Food Chem Toxicol; 2011 Sep; 49(9):2279-84. PubMed ID: 21703324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does equol production determine soy endocrine effects?
    Shor D; Sathyapalan T; Atkin SL; Thatcher NJ
    Eur J Nutr; 2012 Jun; 51(4):389-98. PubMed ID: 22366740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.
    Tseng M; Byrne C; Kurzer MS; Fang CY
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1975-83. PubMed ID: 24019393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification.
    Hwang J; Wang J; Morazzoni P; Hodis HN; Sevanian A
    Free Radic Biol Med; 2003 May; 34(10):1271-82. PubMed ID: 12726915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.